Siilo Raises £8.6 Million to Enable Secure Collaboration Between Healthcare Professionals across Europe
Siilo, the secure collaboration app for healthcare professionals, has raised a £8.6 million (€9.5m) in Series A funding. European digital health VC Heal Capital is at the forefront of the investment, backed by Germany's private health insurers. It is the VC's first investment following the Berlin-based fund’s launch in 2019. Also participating in the round are Philips Health Technology Venture Fund and current investor EQT Ventures.
Read more ...
Philips Launches Pre-Hospital Wireless Monitoring Solution for Emergency Medical Response in U.S.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the U.S. The solution is a complete end-to-end system that combines innovative hardware and advanced software to expand the pre-hospital scope of care for first responders.
Read more ...
NHS Lanarkshire to Advance Scotland's Patient Safety Agenda with Patientrack
An early warning system that helps busy doctors, nurses and other healthcare professionals to quickly identify when patients are at risk of deterioration is to be deployed across hospitals and community settings throughout Lanarkshire.
Read more ...
IBM Watson Health Recognizes Top-Performing U.S. Hospitals and Health Systems
IBM (NYSE: IBM) Watson Health® announced its 2020 Fortune/IBM Watson Health 100 Top Hospitals list and 15 Top Health Systems award winners, naming the top-performing hospitals and health systems in the U.S. Extrapolating the results of this year's studies, if all Medicare hospitalized patients received the same level of care as those treated in the award-winning facilities, more than 100,000 additional lives and billions of dollars in inpatient costs could be saved.
Read more ...
SARS-CoV-2 Antibody Test from Siemens Healthineers Evaluated Against other Leading Antibody Assays in Public Health England Study
Public Health England, in partnership with the University of Oxford, recently conducted a head-to-head evaluation of four commercial immunoassay tests available in the UK and used for the detection of SARS-CoV-2 antibodies.Siemens Healthineers' laboratory-based total antibody test(1) distinguished itself as the only assay tested found to meet both the sensitivity and specificity requirements set out within the Target Product Profile (TPP) for immunoassays by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Read more ...
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices bring new benefits to patients with heart rhythm disorders, including a patient-preferred design without compromising battery longevity and MRI compatibility.
Read more ...
Philips Introduces First-of-a-Kind Mobile ICUs in India to Tackle COVID-19 and other Emergencies
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements of patients, each prefabricated ICU has a capacity of nine beds.
Read more ...